Shares Surge, Confidence Soars—Shilpa’s USFDA Win Reinforces Global Credibility

Unknown Apr 02, 2026 900 Views

Shilpa Medicare Ltd. has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification from the US Food and Drug Administration (USFDA) for its Unit VI facility located in Dabaspet, Bengaluru. This marks the formal closure of the Good Manufacturing Pract...